NEW STUDIES    ONGOING STUDIES 
 
HIV Microbicide 101 Outline (model presentation to be tailored for specific populations)

What is HIV?
HIV (human immunodeficiency virus) is the name of the virus that causes AIDS. Scientists have identifed the virus as a ‹retrovirus,Š which is a virus in a very specific family of viruses. This virus is passed from one person to another through blood-to-blood and sexual contact. In addition, infected pregnant women can pass HIV to their babies during pregnancy, delivery, or breast-feeding.

How is HIV contracted?
HIV is transmitted through the passage of body fluids from an infected person to an uninfected person.
- Blood (such as sharing needles with an injection drug user who is HIV infected)
- Semen
-
Vaginal fluid
- Breast milk
-
Other body fluids containing blood

How is HIV infection prevented?
Safer sex (male and female condoms, non penetrative sex)
- Clean needle use
- Abstinence
- Use of HIV medications during pregnancy
- Avoidance of breast feeding by HIV infected mothers

Why we need new HIV prevention tools?
Despite the fact that we know how to prevent HIV, infections rates continue to increase. What are some reasons for increasing HIV infections despite known methods of prevention? Why donât we always use condoms or clean needles? (IF LEADING A DISCUSSION, ASK FOR RESPONSES FROM AUDIENCE.)
- Desire for pregnancy
- Desire for intimacy
- Forced intimacy
- Faith-based opposition to condoms
- Lack of a clean needle
- Etc

We need alternative HIV prevention methods that will address some of the gaps in safer sex and injection drug use behavior. One new method under research is an HIV microbicide. An HIV microbicide would provide a user-controlled method of prevention independent of partner acceptance.

What is an HIV microbicide?
A "microbicide" is any substance that can substantially reduce transmission of one or more sexually transmitted diseases (STDs) when applied either in the vagina or rectum. Like todayâs spermicides, a microbicide could be produced in many forms, including gels, creams, suppositories, films, lubes or in the form of a sponge or a vaginal ring that slowly releases the active ingredient over time.

How do HIV microbicides work?
Scientists are exploring different approaches to microbicide development. Among these are substances that:
1- kill or otherwise immobilize STD pathogens, including HIV
2- block infection by creating a barrier between the pathogen and the vagina or rectum
3- prevent the infection from taking hold after it has entered the body.

How are HIV microbicides tested?
Potential microbicide products are first tested in the laboratory and in animal models. If these tests show that the substance appears to be safe and shows some ability to protect against HIV, the next step is to try the substances in humans.

Human subject trials proceed through 4 phases:

Phase I - few participants, safety is main objective

Phase II - more participants, safety and immune response are measured

Phase III - hundreds to thousands of participants, safety and effectiveness in HIV prevention are assessed

Phase IV - thousands to tens of thousands of participants, post FDA approval, safety and effectiveness in widespread use.

Status of HIV microbicide research
Numerous phase I trials and a handful of phase II trials have been conducted with potential HIV microbicide products. There has never been a phase III trial of a microbicide product.

Would a microbicide eliminate the need for condoms?
No. When used consistently and correctly, condoms are likely to provide better protection against HIV and STDs, so they will still be the preferred option. But for people who cannot or will not use a condom, and particularly for people whose partners refuse condoms, using microbicides can save lives and have a substantial impact on the epidemic.

Community issues
Microbicide trials need community members to enroll. These trial volunteers need initial and on-going education to understand microbicide research and the particulars about the trial they are joining. Study staff are trained and are ethically bound to provide thorough education.

Beyond study staff, trial volunteers need knowledgeable community advisors and representatives. Community leaders/representatives are needed to learn about microbicide research and to reach out within their community to educate others.

Finally, community activists are needed to continue to safeguard the interests of trial volunteers and to advocate for funding to conduct microbicide research. An effective microbicide could be identified within 5 years with adequate funding and well implemented clinical trials.

Questions for audience
How best do we reach at-risk communities regarding HIV microbicide research?

How do we overcome distrust of the medical community and research in adults?